Early experiments show that a hybrid form of the common pain reliever can effectively inhibit the growth of many tumor types.
Advertisement
The Nutshell
Daily News Roundup
Most Recent
Bioethicist Glenn McGee, founder of the American Journal of Bioethics, resigned from a controversial stem cell company.
A new subtype of the flu virus is identified in Guatemalan yellow-shouldered bats, and the virus may share its genes with the human version.
A chemotherapy medication designed to kill cancer may prevent neuronal death after stroke, according to a study in mice.
UPenn has filed suit against the president of the Memorial Sloan-Kettering Cancer Center for failing to share intellectual property he developed while at the university.
Researchers find the first evidence that a sirtuin gene prolongs life in mice.
Bioethicists debate how to remain impartial as a bioethics journal editor joins company that peddles unproven stem cell therapies.
School-district officials in northwestern New York State are puzzled by a spate of high school students reporting symptoms of the neuropsychiatric disorder.
The world’s first programmable drug-delivery chip passes the test, accurately and safely delivering an osteoporosis drug.
The researcher who helped develop an Alzheimer's treatment now in clinical trials warns that the compound may actually impair memory.
Subjects
- cancer
- cell & molecular biology
- culture
- disease/medicine
- ecology
- evolution
- funding
- genetics & genomics
- NIH
- policy
Sub Categories
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
